Abstract
Computational chemistry has emerged as an indispensable tool in modern drug discovery by enabling the insilico prediction of molecular behavior, interaction, and properties before experimental synthesis. Through techniques such as molecular docking, molecular dynamics simulations, and quantum mechanical calculations, researchers can accelerate the drug development pipeline, reduce costs, and enhance target specificity. This article explores how computational chemistry contributes to target identification, lead optimization, and pharmacokinetic evaluation. We also discuss challenges and future directions, including the integration of artificial intelligence with computational chemistry to further refine drug design.
All articles published in the American Journal of Pharmaceutics are open access and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows users to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given, a link to the license must be provided, and any changes must be indicated.
-
Authors retain full copyright of their work.
-
The journal does not restrict reuse of content, provided proper citation of the original publication is made.